Roundup: Canadian AI well being measurement app Anura involves Singapore and extra briefs


Share post:

NuraLogix introduces well being measurement app in Singapore

Canadian well being AI firm NuraLogix has launched its cellular well being measurement app in Singapore.

Anura makes use of proprietary transdermal optical imaging expertise, which captures blood data from an individual’s face via a video digicam. It could measure numerous important parameters, together with blood stress, coronary heart price, stress degree, cardiac workload, and danger of coronary heart assault and stroke.

The facial blood movement information is then processed through cloud the place an AI engine known as DeepAffex applies superior sign processing and deep studying to foretell physiological and psychological impacts.

The studying course of, in response to the corporate, takes solely 30 seconds.

AI drug discovery agency Standigm companions with Merck Korea

Standigm, an AI drug discovery firm in South Korea, has signed a memorandum of understanding with life science agency Merck Korea for AI-driven drug discovery analysis.

Based mostly on a media launch, the partnership includes Standigm’s adoption of Merck’s AI software program SYNTHIA for compound synthesis.

SYNTHIA is a computer-aided retrosynthetic design device that may rapidly design artificial pathways.

“Making use of AI to the drug discovery course of can dramatically cut back time in discovering novel drug candidates and discovering optimised synthesis paths,” stated Standigm CEO and co-founder Sojeong Yun.

Late final 12 months, Standigm formalised a partnership with Institut Pasteur Korea for creating new anti-tubercular drug candidates via AI.

Nalagenetics will get CE mark for its pharmacogenomics software program

Singaporean biotechnology agency Nalagenetics has obtained a CE mark for its pharmacogenomics software program.

The PGx Core module on its Nala Scientific Choice Assist software program goes with its Nala PGx Core(R) pharmacogenomics testing package, which genotypes lead pharmacogenes.

In keeping with a press assertion, each merchandise are used collectively as a plug-and-play answer for labs with qPCR machines. 

The qPCR testing package can learn 20 variants inside 4 recognized pharmacogenes, CYP2D6, CYP2C9, CYP2C19, and SLCO1B1, whereas the software program can generate greater than 170 drug-gene experiences.

Lately, qPCR testing has been broadly adopted for COVID-19 testing.

“With pharmacogenomics testing changing into an increasing number of ubiquitous world wide, it requires standardised and sturdy instruments to help the fast enhance of adoption,” stated Nalagenetics CEO Levana Sani.

Supply hyperlink


Please enter your comment!
Please enter your name here


Related articles